August 30, 2024

Registration is now open for the Fall 2024 Group Meeting

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

July 24, 2024

Press Release: New England Journal of Medicine publishes practice-changing E1910 trial results

November 15, 2023

Press Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023

October 19, 2023

The September/October News from ECOG-ACRIN blog is now available

February 15, 2023

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

January 5, 2023

The Winter 2023 advocacy blog Considering Clinical Trials is now available

December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group